Quanterix (QTRX) Change in Account Payables (2017 - 2026)
Quanterix (QTRX) posted Change in Account Payables of -$4.8 million for Q1 2026, down 261.05% on a QoQ basis from $3.0 million in Q4 2025, and down 1314.54% year-over-year from $399000.0 in Q1 2025.
Quanterix (QTRX) Change in Account Payables (2017 - 2026) Analysis & Trends
Quanterix's Change in Account Payables history runs 10 years deep, the most recent figure standing at -$4.8 million for Q1 2026.
- Quarterly Change in Account Payables fell 1314.54% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.8 million (down 364.94% YoY) and the FY2025 annual result came in at -$528000.0, down 173.03% from the prior year.
- Change in Account Payables was -$4.8 million for Q1 2026 at Quanterix, down from $3.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.1 million in Q2 2024 and bottomed at -$6.3 million in Q3 2025.
- A 5-year average of -$514647.1 and a median of $241000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables jumped 2128.89% — and 2026, when it tumbled 1314.54%.
- Quanterix's Change in Account Payables stood at $1.7 million in 2022, then sank by 86.01% to $241000.0 in 2023, then tumbled by 43.98% to $135000.0 in 2024, then soared by 2128.89% to $3.0 million in 2025, then tumbled by 261.05% to -$4.8 million in 2026.
- Business Quant data shows QTRX's Change in Account Payables at -$4.8 million in Q1 2026, $3.0 million in Q4 2025, and -$6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -4.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.85 Mn |
| Mar 31, 2026 | -4.85 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Sep 30, 2025 | -6.33 Mn |
| Sep 30, 2025 | -6.33 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 399,000.00 |
| Mar 31, 2025 | 399,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | -1.47 Mn |
| Sep 30, 2024 | -1.47 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | 241,000.00 |
| Dec 31, 2023 | 241,000.00 |